Regenovue Non-Lidocaine: Product Overview for Aesthetic Professionals

Regenovue Non-Lidocaine is a hyaluronic acid (HA) dermal filler manufactured by NeoGenesis Co., Ltd. in South Korea. This product is formulated without lidocaine, offering an alternative for practitioners whose patients require or prefer lidocaine-free options. As part of a broader category of Hyaluronic acid dermal filler catalog, Regenovue is a recognized option for various facial contouring. Understanding its specific characteristics is essential for clinics to align with patient needs and treatment protocols.

Regenovue Non-Lidocaine consists of cross-linked hyaluronic acid, delivered in a pre-filled syringe. The HA concentration and cross-linking degree are engineered for specific viscoelasticity and cohesivity. These properties are suitable for various professional applications, aiming for predictable injection and integration. Each unit typically includes 1.1 ml of product and accompanying sterile needles for immediate professional use.

Aesthetic professionals utilize Regenovue Non-Lidocaine for indications requiring volume enhancement and contouring. This includes correcting facial wrinkles and folds, restoring volume, and enhancing features. The absence of lidocaine allows practitioners flexibility in patient comfort management. Proper injection technique and anatomical knowledge are paramount for achieving intended aesthetic outcomes. Other non-lidocaine options like Elasty Plus Non-Lido 2CC are also available.

The duration of effects from HA dermal fillers, including Regenovue Non-Lidocaine, varies due to physiological and product-specific factors. These involve the injection area, patient metabolism, and the filler's cross-linking technology. HA fillers offer temporary volume and contouring, biodegrading gradually. Practitioners should inform patients that maintenance treatments are generally needed to sustain results, managing expectations.

Sourcing Regenovue Non-Lidocaine involves understanding wholesale options and volume tiers. An illustrative price of $75.8 per unit may apply, with volume discounts available: 11 units (4% off), 21 units (5% off), 31 units (6% off), and 51+ units (8% off). Clinics should assess inventory needs for efficient procurement. Distributors often offer flexibility with Minimum Order Quantity (MOQ). For other sourcing considerations, refer to guides like D.Fill Soft Wholesale Price Guide.

Ensuring the integrity of Regenovue Non-Lidocaine is critical. Products require adherence to manufacturer-specified storage conditions, including a controlled cold chain during transit and clinic storage. Maintaining recommended temperatures protects the stability and efficacy of the HA formulation. Upon receipt, clinics must verify packaging and labeling. Accurate inventory management supports patient safety and operational efficiency.